These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38953453)

  • 1. Identification of Innovative Folate Inhibitors Leveraging the Amino Dihydrotriazine Motif from Cycloguanil for Their Potential as Anti-
    Francesconi V; Rizzo M; Pozzi C; Tagliazucchi L; Konchie Simo CU; Saporito G; Landi G; Mangani S; Carbone A; Schenone S; Santarém N; Tavares J; Cordeiro-da-Silva A; Costi MP; Tonelli M
    ACS Infect Dis; 2024 Jul; ():. PubMed ID: 38953453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of
    Tassone G; Landi G; Linciano P; Francesconi V; Tonelli M; Tagliazucchi L; Costi MP; Mangani S; Pozzi C
    Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34209148
    [No Abstract]   [Full Text] [Related]  

  • 3. In Silico and In Vitro Search for Dual Inhibitors of the
    Possart K; Herrmann FC; Jose J; Schmidt TJ
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Potential Inhibitors of Pteridine Reductase 1 in
    Kimuda MP; Laming D; Hoppe HC; Tastan Bishop Ö
    Molecules; 2019 Jan; 24(1):. PubMed ID: 30609681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sesquiterpene Lactones with Dual Inhibitory Activity against the
    Possart K; Herrmann FC; Jose J; Costi MP; Schmidt TJ
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor.
    Landi G; Linciano P; Tassone G; Costi MP; Mangani S; Pozzi C
    Acta Crystallogr D Struct Biol; 2020 Jun; 76(Pt 6):558-564. PubMed ID: 32496217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Insights into the Development of Cycloguanil Derivatives as
    Landi G; Linciano P; Borsari C; Bertolacini CP; Moraes CB; Cordeiro-da-Silva A; Gul S; Witt G; Kuzikov M; Costi MP; Pozzi C; Mangani S
    ACS Infect Dis; 2019 Jul; 5(7):1105-1114. PubMed ID: 31012301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents.
    Linciano P; Pozzi C; Tassone G; Landi G; Mangani S; Santucci M; Luciani R; Ferrari S; Santarem N; Tagliazucchi L; Cordeiro-da-Silva A; Tonelli M; Tondi D; Bertarini L; Gul S; Witt G; Moraes CB; Costantino L; Costi MP
    Eur J Med Chem; 2024 Jan; 264():115946. PubMed ID: 38043491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
    Cavazzuti A; Paglietti G; Hunter WN; Gamarro F; Piras S; Loriga M; Allecca S; Corona P; McLuskey K; Tulloch L; Gibellini F; Ferrari S; Costi MP
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1448-53. PubMed ID: 18245389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit
    Linciano P; Dawson A; Pöhner I; Costa DM; Sá MS; Cordeiro-da-Silva A; Luciani R; Gul S; Witt G; Ellinger B; Kuzikov M; Gribbon P; Reinshagen J; Wolf M; Behrens B; Hannaert V; Michels PAM; Nerini E; Pozzi C; di Pisa F; Landi G; Santarem N; Ferrari S; Saxena P; Lazzari S; Cannazza G; Freitas-Junior LH; Moraes CB; Pascoalino BS; Alcântara LM; Bertolacini CP; Fontana V; Wittig U; Müller W; Wade RC; Hunter WN; Mangani S; Costantino L; Costi MP
    ACS Omega; 2017 Sep; 2(9):5666-5683. PubMed ID: 28983525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum.
    Bhattacharya A; Leprohon P; Ouellette M
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009377. PubMed ID: 33905412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity.
    Di Pisa F; Landi G; Dello Iacono L; Pozzi C; Borsari C; Ferrari S; Santucci M; Santarem N; Cordeiro-da-Silva A; Moraes CB; Alcantara LM; Fontana V; Freitas-Junior LH; Gul S; Kuzikov M; Behrens B; Pöhner I; Wade RC; Costi MP; Mangani S
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28282886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual and selective inhibitors of pteridine reductase 1 (PTR1) and dihydrofolate reductase-thymidylate synthase (DHFR-TS) from
    Teixeira BVF; Teles ALB; Silva SGD; Brito CCB; Freitas HF; Pires ABL; Froes TQ; Castilho MS
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1439-1450. PubMed ID: 31409157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major.
    Nare B; Hardy LW; Beverley SM
    J Biol Chem; 1997 May; 272(21):13883-91. PubMed ID: 9153248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophore Mapping, In Silico Screening and Molecular Docking to Identify Selective Trypanosoma brucei Pteridine Reductase Inhibitors.
    Dube D; Sharma S; Singh TP; Kaur P
    Mol Inform; 2014 Feb; 33(2):124-34. PubMed ID: 27485569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
    Pöhner I; Quotadamo A; Panecka-Hofman J; Luciani R; Santucci M; Linciano P; Landi G; Di Pisa F; Dello Iacono L; Pozzi C; Mangani S; Gul S; Witt G; Ellinger B; Kuzikov M; Santarem N; Cordeiro-da-Silva A; Costi MP; Venturelli A; Wade RC
    J Med Chem; 2022 Jul; 65(13):9011-9033. PubMed ID: 35675511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
    Linciano P; Pozzi C; Iacono LD; di Pisa F; Landi G; Bonucci A; Gul S; Kuzikov M; Ellinger B; Witt G; Santarem N; Baptista C; Franco C; Moraes CB; Müller W; Wittig U; Luciani R; Sesenna A; Quotadamo A; Ferrari S; Pöhner I; Cordeiro-da-Silva A; Mangani S; Costantino L; Costi MP
    J Med Chem; 2019 Apr; 62(8):3989-4012. PubMed ID: 30908048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
    Tulloch LB; Martini VP; Iulek J; Huggan JK; Lee JH; Gibson CL; Smith TK; Suckling CJ; Hunter WN
    J Med Chem; 2010 Jan; 53(1):221-9. PubMed ID: 19916554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases.
    Santucci M; Luciani R; Gianquinto E; Pozzi C; Pisa FD; Dello Iacono L; Landi G; Tagliazucchi L; Mangani S; Spyrakis F; Costi MP
    Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
    Hardy LW; Matthews W; Nare B; Beverley SM
    Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.